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Background.The early detection of rheumatic diseases and the treatment to target have become of utmost importance to control the
disease and improve its prognosis. However, establishing a diagnosis in early stages is challenging as many diseases initially present
with similar symptoms and signs. Expert systems are computer programs designed to support the human decisionmaking and have
been developed in almost every field of medicine.Methods. This review focuses on the developments in the field of rheumatology
to give a comprehensive insight. Medline, Embase, and Cochrane Library were searched. Results. Reports of 25 expert systems with
different design and field of application were found. The performance of 19 of the identified expert systems was evaluated. The
proportion of correctly diagnosed cases was between 43.1 and 99.9%. Sensitivity and specificity ranged from 62 to 100 and 88 to
98%, respectively. Conclusions. Promising diagnostic expert systems with moderate to excellent performance were identified. The
validation process was in general underappreciated. None of the systems, however, seemed to have succeeded in daily practice.This
review identifies optimal characteristics to increase the survival rate of expert systems and may serve as valuable information for
future developments in the field.
1. Introduction
Rheumatologic diseasesmanifest themselves in varying com-
binations of symptoms and signs, particularly at early stages,
and therefore make differential diagnosis a challenge, espe-
cially for nonrheumatologists including general practitioners.
Since diagnosis at an early stage and adequate treatment
improve prognosis, assistance in establishing diagnosis is
desirable. Given the substantial progress in computer science
in the last years, the idea of computers taking the role of diag-
nostic support is not far-fetched. Software applications have
affected decision processes in clinical routine, for example,
in controlling depth of anesthesia [1] or in detecting drug
interactions [2]. Software tools to support physicians in the
diagnostic process have been developed in almost every field
of medicine. A widely utilized type is the so-called expert
system, defined as artificial intelligence program designed
to provide expert-level solutions to complex problems [3].
Figures 1 and 2 give an overview of the concept.
Pandey and Mishra distinguished between knowledge-
based systems and intelligent computing systems [4]. There
are three different approaches to knowledge-based systems
depending on the form of knowledge representation: rule
based, case based, and model based. In rule based reasoning,
the knowledge is expressed by rules, often IF⋅ ⋅ ⋅ THEN⋅ ⋅ ⋅
rules [4]. The rules can be newly developed or can be
extracted from decision tables or decision trees [5]. In
case of based reasoning, the inference engine searches the
knowledge base for similar cases. Finally, models, that is,
biochemical or biophysical, can also form the knowledge [4].
The typical knowledge-based expert system consists of four
parts. Figure 2 illustrates its structure.
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Figure 1: Common methodologies for expert systems.
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Figure 2: Typical structure of a knowledge-based expert system.
Based on Buchanan [3], the user interface allows the nonexpert to
enter the symptoms and findings [3] and presents the diagnostic
output.The knowledge base provides the knowledge. Different ways
of representation, such as rules, models, or cases, can be chosen.
The inference engine examines the knowledge base and produces
reasoning [15]. The knowledge engineering tool allows for changing
or enlarging the knowledge base by adding further rules, cases, or
models [7]. There may also be an explaining component, which
illustrates the diagnostic process and which gives a rationale [7].
A knowledge-based expert system with an empty knowledge base
is called shell. It can be used for the development of other expert
systems by adding a new knowledge base [7].
The approaches to intelligent computing systems are arti-
ficial neuron nets, genetic algorithm, and fuzzy systems. Arti-
ficial neuron nets are built like biologic intelligent nervous
systems and are regarded as learn-like [4]. Individual vari-
ables receive inhibitory and excitatory inputs like neurons.
The calculations are made in parallel, not only sequentially
like in other methodologies [6]. Genetic algorithm mimics
the process of natural evolution and is mainly used in search
processes. Fuzzy systems are usually based on rules, but
the reasoning is approximate to cope with uncertainty and
imprecision because the rules are given varying truth-value
using fuzzy sets [7]. Thus, linguistic certainty or frequency
levels, such as probable or seldom, derived frommedical texts
or experts can be incorporated into the knowledge base [8].
Bayes’ theorem is a statisticalmethod.The probability of a
diagnosis is calculated with the accuracy of a test or a clinical
finding and the prevalence of the disease [9]. Thus Bayes’
theorem sets probabilistic values for each diagnostic output
[4].
Different methodologies are often combined, which are
then called hybrid expert systems [10].
Already in 1959, Ledley and Lusted anticipated the use
of computers in supporting decisions and proposed different
mathematical models to emulate the reasoning in medical
diagnosis [11]. Since then, the number of expert systems in
medicine has grown rapidly. The first expert systems were
developed in the 1970’s. Two well-known pioneer expert sys-
tems are MYCIN and INTERNIST-1. They were archetypes
for following expert systems, but they also demonstrated
the challenges in the development of such tools. MYCIN
was developed at the Stanford University in the 1970s. It
was used for diagnosis and therapy of bacterial infection
and has become the probably best-known expert system in
medicine [3]. INTERNIST-1 was developed at the University
of Pittsburgh [12]. It was designed to assist physicians in
the diagnosis of complex and multiple diseases in internal
medicine covering more than five hundred diseases [13]. The
problems encountered in developing INTERNIST-1 and its
successors showed that a comprehensive knowledge base is
needed for a correct diagnosis of complex diseases in internal
medicine [7].
Several somewhat outdated review articles explored the
development and application of expert systems inmedicine in
general [4, 10, 14]. In 1991, Bernelot Moens and van der Korst
reviewed the literature assessing computer-assisted diagnosis
of rheumatic diseases [15]. Meanwhile, also in rheumatology
new expert systems have emerged and earlier expert systems
have been improved to meet the many demands of modern
rheumatology: establishing an early diagnosis with the high-
est probability to allow for a better outcome with the help of
a prompt treatment.
Besides an overview of characteristics, comprehensive-
ness, and validation of existing diagnostic expert systems
in rheumatology, this systematic review seeks to point out
whether the current expert systems fulfill the expectations of
clinicians in daily practice and finally what the characteristics
of an optimal system would be.
2. Methods
The systematic literature review was carried out following the
PRISMA statement [16]. No ethics board approval or consent
of any individual was necessary. The research questions
were as follows: what information is currently available on
diagnostic expert systems in rheumatology, how do these
systems work, what is their validity and their applicability in
daily practice, and finally what is an optimal diagnostic expert
system expected to be.
2.1. Scenarios. In the optimal scenario we anticipated to find
comprehensive reports on each individual diagnostic expert
system including information on the precise diagnostic
algorithm, the targeted diseases, a well-described validation
cohort, and predictive values for diagnostic performance.
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The data would allow for a statistical comparison of the
expert systems. In a suboptimal scenario, only descriptive
reports of expert systems will be found allowing for a
comprehensive overview of the past developments without
statistical comparability.
2.2. Systematic Literature Search. Medline, Embase, and
Cochrane Library were searched using the following Med-
ical Subject Heading (MESH) terms: “rheumatic diseases,”
“rheumatology,” “arthritis,” “computer assisted diagnosis,”
and “expert systems.” No restrictions were placed on pub-
lication date. Only literature in English or German was
considered. The last search was run on February 10, 2014.
2.3. Selection of Articles. The literature was screened based on
title and abstract of the records. All publications referring to
diagnostic expert systems in rheumatology or in a rheumatic
subfield were included. Reviews, editorials, and literature
which described an expert system only used for education
of healthcare providers and therefore not used in diagnostics
were excluded. Also, literature that referred to an expert
system used for identifying solely the stage of a disease and
hence not used for diagnosing a disease itself was excluded.
Records which described an expert system applied only to
image analysis were not considered either. Literature refer-
ring to data mining strategies using index diagnoses or solely
epidemiological variables was excluded as well. Figure 3
shows a flow diagram of the selection of studies. In case of
uncertainties, inclusion or exclusion was based on consensus.
2.4. Data Extraction and Statistical Analysis. Year of the
last update of the system, number of considered rheumatic
diseases, targeted diseases, information to feed the expert
systems (history, clinical exam, laboratory analyses, and
imaging studies), methodology of the inference mechanism,
and embedding of accepted disease criteria sets such as the
American College of Rheumatology (ACR) or The Euro-
pean League Against Rheumatism (EULAR) criteria were
extracted using standard forms.
For the description of the validation method and the
performance, the following information was extracted from
the articles: number of cases used for the validation, determi-
nation of the resulting diagnosis, identification of the correct
diagnosis, the reference diagnosis, percentage of correctly
identified cases, sensitivity and specificity, positive predictive
values, negative predictive values, positive likelihood ratio,
and negative likelihood ratio.
Only descriptive statistics are reported. Statistical analy-
ses could not be performed due to the lack of information.
3. Results
3.1. Literature Searches. A total of 10,282 references were
identified using the search strategy. Seventy-three articles
related to diagnostic expert systems in rheumatology were
included. Nine duplicates were excluded. The remaining 64
full text articles were then assessed. One record describing
an expert system developed solely for education [17] and one
Number of records identified through database search
Cochrane LibraryEmbaseMedline
38 articles included
n = 498 n = 28
(n = 14)
Articles screened on basis of title and abstract 
Not referring to a diagnostic ES†
Not referring to a diagnostic ES†
Full text articles assessed (n = 64)
Duplicates removed (n = 9)
ES† used for education (n = 1)
Diagnostic index codes used (n = 1)
Reviews or editorials (n = 6)
Articles with repeat data (n = 4)
n = 9,756
(n = 10,282 )
(n = 10,209)
Figure 3: Selection of publications.
record referring to an expert system that was not designed for
clinical use [18] were excluded. Six reviews or editorials were
excluded [6, 15, 19–22]. In the case of repeated reports, either
the original or the more comprehensive article was included
in the evaluation leading to a final number of 38 original
articles (Figure 3). In these 38 articles, 25 different expert
systems and their successors or further developments are
presented.Most of the articles shown in this review presented
the development and the methodology of expert systems.
3.2. Characteristics of the Identified Expert Systems. Table 1
gives an overview over the 25 identified expert systems
and their characteristics. The number of considered diseases
varies from one to 170. Both the amount and the nature of
information to feed the expert systems vary according to the
targeted disease group and inference mechanisms. The fol-
lowing methodologies of expert systems were observed: rule
based, case based, model based, artificial neuron nets, fuzzy
systems, Bayes’ theorem, and other not further described
algorithms or calculation tools (Figure 1). Rule-based systems
were the most frequent. Twelve different spectra of targeted
diseases were found. Six expert systems used ACR or EULAR
criteria to establish a diagnosis.
3.3. Validation. Table 2 summarizes the validation of the
expert systems. 19 of the 25 expert systems (76%) were
validated. The number of cases used for the validation
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Table 1: Characteristics of the identified expert systems.
Name of ESa or first
author
Year of last
update
Number of
diseases Targeted diseases Input for ES
a Methodology Reference
Romano 2009 2 Prosthesis infection Lb, Ic Calculation tool [23]
Watt 2008 1 Knee osteoarthritis Hd, Ee, Ic Bayesian beliefnetwork [24]
Provenzano 2007 3 Chronic pain Hd Discriminant analysis [25]
Binder 2005 5 Connective tissuediseases L
b Case based reasoning [26]
Liuf 2004 1 RAg Hd, Lb Algorithm [27]
Lim 2002 24 Arthritic diseases Hierarchical fuzzyinference [28]
CADIAGf 2001 170 Rheumatic diseases Hd, Ee, Lb, Ic Rule based, fuzzy sets [8, 29–33]
RENOIRf 2001 37 Rheumatic diseases Hd, Ee, Lb, Ic Rule based, fuzzy sets [34–36]
RHEUMexpert 1999 Rheumatic diseases Hd, Ee, Lb, Ic Rule based [37]
Zupan 1998 8 Rheumatic diseases Hd Rule based [38]
AI/RHEUM 1998 59 Rheumatic diseases Hd, Ee, Lb, Ic Rule based [39–43]
Dzeroski 1996 8 Rheumatic diseases Hd Rule based andstatistical [44]
Hellerf 1995 6 Vasculitis Hd, Ee, Lb Bayesian classifier [45]
Astion 1994 1 Giant cell arteritis Hd, Ee, Lb Neural networks [46]
Barreto 1993 2 RAg and SLEh Hd, Ee, Lb, Ic Neural networks,fuzzy sets [47]
MESICAR 1993 Rheumatic diseases Model based [48]
RHEUMA 1993 67 Rheumatic diseases Hd, Ee, Lb, Ic Rule based [49]
Bernelot Moens 1992 15 Rheumatic diseases Hd, Ee, Lb, Ic Bayes’ Theorem [50–52]
Sereni 1991 1 Temporal arteritis Hd, Ee, Lb Bayes’ Theorem,decision tree [53]
Rigby 1991 1 RAg Hd, Ee Bayesian and logisticregression [54]
Schewef 1990 32 Knee pain Hd Rule based [55]
Prust 1986 2 Ankylosingspondylitis and SLEh H
d, Ee Scoring tool [56]
Gini 1980 7 Arthritic diseases Hd Rule based [57]
Dosta´l 1972 1 RAg Hd Bayes’ Theorem [58]
Fries 1970 35 Arthritic diseases Hd Statistical [59]
aES: xpert system, bL: laboratory results, cI: imaging results, dM:medical history, eE: physical examination, fACR or EULAR criteria included, gRA: rheumatoid
arthritis, hSLE: systemic lupus erythematosus.
varied widely between 32 real cases and 12 000 simulated
patients. Different units of measurement were selected to
report the performance of the expert systems, mostly the
percentage of correctly diagnosed cases, sensitivity and
specificity. The proportion of correctly diagnosed cases—the
diagnostic accuracy—was between 43.1 and 99.9%. Values for
sensitivity and specificity ranged from 62 to 100, and 88 to
98%, respectively. Positive or negative predictive values and
likelihood ratios were only surveyed for two expert systems
[26, 27]. Liu et al. reached a positive predictive value of 91%.
Binder et al. showed a positive likelihood ratio of 12.1 (95%
CI 7.70–19.1) and a negative likelihood ratio of 0.187 (95% CI
0.099–0.351). Excluding this last report, confidence intervals
were not indicated.
The reference standards were chosen differently: diag-
noses according to established criteria, consensus diagnoses,
discharge diagnoses, and diagnoses provided by a rheuma-
tologist were used most often as reference. Three expert
systems presented certain criteria for the determination of the
resulting diagnosis when several diagnoses were presented
as a result or when a probability value was added to the
diagnosis. Table 3 presents the chosen reference diagnoses
and the determinations of the resulting diagnoses.
An article that reports on the applicability of a rheuma-
tological expert system in clinical routine could not be
identified in the published literature.
4. Discussion
The main result of this systematic review is threefold. First,
an overview over 25 different diagnostic expert systems
designed for rheumatology is given. Second, it is shown that
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Table 2: Validation of the identified expert systems.
Name of ESa or first
author
Number of cases used
for validation
Percentage of
diagnoses correct Sensitivity Specificity Reference
Romano 32 [23]
Watt 200 100% [24]
Provenzano 511 22.9–69.7%b [25]
Binder 325 82.6%CIc: 68.0–91.7
93.2%
CIc: 89.4–95.7 [26]
Liu 90 95% 100% 88% [27]
Lim No validation [28]
CADIAGd 54 48%e [29]
RENOIRd 32 75% [36]
RHEUMexpert 252 32–77%f 70–73%f [37]
Zupan 462 46.8%SDg: 3.9 [38]
AI/RHEUMd 94 80% [42]
Dzeroski 462 47.2–50.9%b [44]
Heller 12000 computersimulated cases 84.15–99.9%
f [45]
Astion 807 94.4% 91.9% [46]
Barreto No validation [47]
MESICAR No validation [48]
RHEUMA 51 89%e [49]
Bernelot Moensd 570 76%/80%
b
SEh: 10.2/9.5 62% 98% [51]
Sereni 341 [53]
Rigby No validation [54]
Schewe 358 74.4% [55]
Prust No validation [56]
Gini No validation [57]
Dosta´l 553 80% [58]
Fries 190 76% [59]
aExpert system, bmultiple formulas were applied, cCI: 95% confidence interval, dmore than one evaluation, eevaluated in other clinic than developed, fresults
depending on disease, gSD: standard deviation, hSE: standard error.
the different designs and validation methods of the expert
systems hinder the comparison of their performances.Third,
we foundnopublications reporting on the routine application
of an expert system in rheumatology.
Artificial intelligence has achieved enormous progress
in its development and computers have outclassed human
beings in various fields, such as computer chess or IBM’sWat-
sonwinning on the quiz show “Jeopardy!”Given this progress
in technology and the time period covered by this systematic
review of over forty years, the low number of identified expert
system is surprising.The reasons would be either low interest
in supportive software or, more likely, the difficulties encoun-
tered in simulating the complex human diagnostic process.
Spreckelsen et al. [60] reported that developers of knowledge-
based systems regarded pharmacovigilance, intensive care
monitoring, and support for guidelines and clinical pathways
as the most promising fields of knowledge-based systems.
In other words, systems covering clearly defined decision
rules or comparing databases. Diagnostic support was less
favorably judged. In rheumatology in particular, the diag-
nostic process is hampered by multiple factors. First of all,
nonspecific findings occurring inmultiple rheumatic diseases
are common and consequently complicate the knowledge
representation in expert systems. Second, there is a lack
of epidemiological data concerning the prevalence and
incidence of rheumatic diseases as well as sensitivity and
the specificity of single findings in diseases. Third, even
if available for a large population, such data vary greatly
amongst ethnic groups and regions becoming an increasing
problem in times of global migration. Fourth, for many
of the disease-specific findings, there are no internationally
established standardized cut-off values. And finally, many
rheumatic diseases can coexist with each other in overlap
syndromes.
Nevertheless, the growing understanding of diseases and
the corresponding findings or symptoms will facilitate the
representation of medical knowledge and decision processes
in the future.
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Table 3: Reference diagnoses and the determinations of the resulting diagnoses.
Name of ES† or first
author Reference diagnosis Determination of the resulting diagnosis Reference
§
Watt NIH Osteoarthritis initiative data base [24]
Binder Diagnosis according to established criteria [26]
Liu Consensus of rheumatologists [27]
CADIAG Discharge diagnosis Among first 5 hypotheses [29]
RENOIR Discharge diagnosis [36]
RHEUMexpert Discharge diagnosis [37]
AI/RHEUM Initial diagnosis of a rheumatologist At the possible level [42]
Astion Vasculitis database of the American College of Rheumatology [46]
RHEUMA Discharge diagnosis [49]
Bernelot Moens Outcome over time and consensus of rheumatologists [51]
Sereni Biopsy [53]
Schewe In the hypotheses list [55]
Dosta´l Diagnosis provided by a rheumatologist [58]
Fries Diagnosis provided by a rheumatologist [59]
†ES: expert system, §reference.
4.1. Validation of Expert Systems. In consequence of the
variation in themethod of validation, the achieved validation
results could not be compared with each other.The reason for
this variability probably lies in two elements.
First, the result of the expert systems to be compared with
the reference diagnosis was presented in different ways. Some
expert systems indicated a probability value of the calculated
resulting diagnosis, and others present a hypotheses list.
Final diagnoses in rheumatology often remain descriptive or
incomplete and evolve over time as many of the rheumatic
disorders present atypically and do not completely fulfill a
diagnostic criteria set at the beginning.This issue ismet by the
presentation of the results as a hypotheses list or probability
values, which can, as an important advantage, multiply the
user’s own differential diagnosis and lead to more focused
testing. Yet, this method causes difficulties in the validation
and the comparison of expert systems. For example, the
diagnostic accuracy is erroneously high if a diagnosis at a
low position in the hypotheses list or a diagnosis with a low
probability value is accepted as a correct resulting diagnosis
during the validation process.
Second, there is a lack of widely accepted reference
standards for the correct diagnosis to compare the resulting
diagnosis with. Some authors used diagnoses in medical
records or discharge diagnoses as a comparator assuming
the correctness of their peers, some chose the consensus
of rheumatologists, and others used diagnoses according to
official diagnostic criteria sets.The latter is probably the most
reliable way; however, even if international consensus criteria
exist, there are still many different criteria sets especially for
rare diseases where the superiority of one set over the other
and in particular the threshold for a diagnosis remains a
matter of debate. In addition, many of these criteria sets were
established to obtain homogenous cohorts in clinical trials
leading to a low sensitivity in early or mild disease.
Another approach was the assessment of the interob-
server variability by Hernandez et al. [34] and Mart´ın-
Baranera et al. [35]. Here, the distance between the resulting
diagnoses of clinicians and RENOIR was calculated without
setting a reference diagnosis. By thismeans the uncertainty of
the final diagnosis and the error proneness of clinicians were
taken into account.
The transferability of expert systems to the general popu-
lation (the external validity) can be tested with a validation in
a developer-independent clinical setting. Only AI/RHEUM,
CADIAG, and RHEUMA [29, 39, 40, 49] were validated this
way, resulting in a lack of data on the transferability to daily
practice of most of the presently available expert systems.
4.2. Clinical Use and Requirements of Expert Systems in Prac-
tice. Besides the internal and external validity, the following
features are, according to Kawamoto et al., highly associated
with an expert system’s ability to improve clinical practice:
the availability at the time and location of decision making,
the integration into clinical workflow, and the provision of
recommendations rather than a pure assessment [61]. The
wider use of computers in clinical routine, such as the possible
use of tablet computers on ward rounds, will facilitate the
integration into clinical workflow and enhance the availabil-
ity at the time and location of decision making. The need
of more detailed documentation for quality assurance may
have a positive influence as well. Boegl et al. are the only
authors who reported the clinical use of their diagnostic
expert system Cadiag-4/Rheuma-Radio. The expert system
was incorporated in the medical information system of
the respective clinic [30]. For the lack of accessibility of
diagnostic support, the universally present search engines for
theWorldWideWeb have become a popular alternative with
an astonishing accuracy as shown by Tang and Ng [62] and
Lombardi et al. [63].
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Kolarz et al. [37] and Schewe and Schreiber [49] regarded
the time required for data input as the most limiting factor.
Considering the smaller amount of input data and conse-
quently the shorter input time, specialized and restricted
expert systems like the laboratory results analyzing system
presented by Binder et al. [26] have the edge over more
comprehensive systems. Kaplan [41] presented a system
with a provisional hypothesis list, which updates after every
further input. Here, the data input is limited; hence, there is a
risk ofmissed diagnoses due to the less thorough questioning.
The required time for data input would decrease if the expert
system was compatible with the institutional medical infor-
mation system and consequently could allow direct access to
all electronically stored patient data comprising patient his-
tory, physical exam, imaging studies, and laboratory analyses.
The latter include the increasingly important biomarkers [64,
65]. Then again the data input and the required time depend
on an intuitive user interface, which Boegl et al. believed to
have the biggest influence on the clinical success [30].
The reason for the absence of expert systems in clinical
use hitherto has been discussed in detail in the literature.
Mandl and Kohane claimed that health information technol-
ogy in general was in arrears compared to other industries.
Also they took the health information technology products
as too specific and incompatible with each other [66]. Spreck-
elsen et al. evaluated an online survey of researchers and
developers of knowledge-based systems. They stated that the
lack of acceptance by the medical staff is the main problem in
the application of knowledge-based systems inmedicine [60].
The different points of view of developers and clinicians show
that a better cooperation is necessary. Expert systems have to
be adapted to clinical problems and to clinical workflow. On
the other hand, clinicians should become more aware of the
supportive possibilities of expert systems.
4.3. Importance of Targeted User Group. In spite of com-
puterized assistance, the user of the expert system needs
rheumatologic fundamentals for the detection and the
correct description of rheumatologic findings. CADIAG,
AI/RHEUM, RENOIR, RHEUMexpert, and MESICAR were
specifically developed for the assistance of nonrheumatol-
ogists [31, 37, 39, 48, 50]. These systems were designed to
remind the nonspecialist of rare diseases or to indicate the
cases which needed immediate treatment. Yet, an expert
system’s outcome highly depends on the entry of correct
parameters.Therefore, educational parts were added to some
of the expert systems to increase the user’s diagnostic skills.
These educational parts explain certain symptoms or show
photographs of findings [30, 42, 51]. Also, some systems
provided a link to literature, such as Medline, for further
information [30, 42]. The AI/RHEUM and CADIAG project
presented the most extensive educational parts. A widely
accepted system ideally covers the demands of generalists and
specialists offering an easy understandable handling and not
being too basic at the same time.
4.4. Diagnostic Criteria Sets. The integration of widely
accepted diagnostic criteria sets such as the ACR or EULAR
criteria into the diagnostic process would increase the accep-
tance and credibility of an expert system. It also reduces the
influence of individual diagnostic strategies of the develop-
ers. Nevertheless, only six of the identified expert systems
reported the integration of such criteria sets into their expert
database. The downside of diagnostic criteria originating
primarily from classification criteria for the inclusion into
clinical trials, however, is the generally low sensitivity in early
disease. This insensitivity of some criteria, such as the 1987
ARA criteria for rheumatoid arthritis, forced Leitich et al. to
modify the criteria using fuzzy sets to gain different levels of
sensitivity [32]. The recent development of official diagnostic
criteria, which are more dedicated to the diagnosis in an
early stage of the disease [67], will make their use in the
design of expert systems more attractive. Furthermore, some
methodologies are ill suited to the use of diagnostic criteria,
such as a mere probabilistic approach like Bayes’ theorem
or artificial neural network. These systems extract their
knowledge base from patient data, such as symptoms and
clinical findings, and the corresponding diagnoses assuming
a correctness of the chosen diagnosis. Diagnostic criteria
cannot be included in these systems without the combination
with another methodology or an adaption of the reasoning
process like the review of symptom weighing. Other ways
of knowledge representation facilitate the usage of official
diagnostic criteria, like rule-based reasoning though the
minority of the articles presenting a rule-based expert system
reported an integration of official diagnostic criteria.
4.5. Limitations. Although a thorough systematic search has
been performed in the most relevant databases, some reports
could have been missed if written in other languages than
English or German. As most of the current literature is
published in English at least as an abstract, we are confident
that we did not miss relevant articles on diagnostic expert
systems in rheumatology. The number of expert systems
which have remained unpublished because of their expected
commercial use or the abortion of the system at an early stage
is hard to estimate.
The reported expert systems showed a great variety in
diseases spectrum, methodology, and validation status. This
made a statistical comparison of the systems impossible.
And finally, the important topic of patient reported
outcomes which are of increasing importance not only in
clinical trials and patient’s follow-up but also in the diagnostic
process was beyond the scope of this review.
5. Conclusion
In conclusion, this systematic review shows that the many
attempts made for an ideal expert system in rheumatology in
the past decades have not yet resulted in convincing validated
tools allowing for reliable application in daily practice. Never-
theless, the demand in support by expert systems is pressing
as the knowledge about the rheumatic diseases increases
and the therapeutic options especially in early disease stages
are growing constantly. An ideal diagnostic expert system
in rheumatology would have the following characteristics.
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The expert system would allow for universal integration
into the clinical workflow as well as rapid and intuitive
data input. Since rheumatologic diagnoses cannot always be
definite, the resulting diagnosis would have a probabilistic
grade to indicate uncertainty. The system would also have an
educational component to improve the nonexpert’s ability to
recognize pathological findings. Finally, accepted diagnostic
criteria sets would be applied to increase the general validity
of the system’s diagnostic process.
Based on the demand of such a tool and the progress
made hitherto it seems to be a matter of time until new and
promising expert systems enter clinical practice.
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